National Association of Boards of Pharmacy

Cancer medicine treatments face pharmaceutical supply chain challenges, including drug shortages and reports of counterfeit medicines reaching U.S. clinics. Efforts to strengthen safety involve legislative solutions like the proposed Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act and regulatory improvements by organizations such as NABP. Furthermore, patient education is stressed as essential so that individuals understand if a medication is FDA-approved or compounded for an individual need.